Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Marlboro maker cuts profit forecast as smokers swap to cheaper brands

Published 10/26/2023, 07:55 AM
Updated 10/26/2023, 10:17 AM
© Reuters. FILE PHOTO: A woman poses with a cigarette in front of Altria logo in this illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) -Tobacco giant Altria Group (NYSE:MO) cut its annual profit forecast on Thursday as more smokers swapped its higher priced cigarettes for cheaper brands or smoking alternatives, sending the Marlboro maker's shares lower.

The company said it now expects adjusted profit of $4.91 to $4.98 per share this year, compared with a previous forecast of $4.89 to $5.03 per share.

Altria has been hiking prices of its traditional products to offset volume declines as many consumers, wary of health risks, opt for new options like vapes or oral nicotine.

But price increases hit Marlboro's market share, Altria said, as inflation-weary consumers try to conserve cash by switching to cheaper brands like USA Gold.

Net revenue from smokeable products fell 5.3% in the third quarter, as higher pricing only partially offset lower shipment volumes and higher promotional investments.

Chief Executive Billy Gifford noted Altria's cigarette business remained "highly profitable", providing fuel for the company's switch to smoking alternatives.

Altria's shares were down 3.5% by 1408 GMT.

Rae Maile, analyst at Panmure Gordon, said Altria was still effectively leveraging its ability to raise prices to maintain revenues and profit.

"The model is not broken," he said, adding Altria's profits remained at similar levels to last year despite volume declines.

Altria is also continuing its push into smoking alternatives, following a disastrous foray into e-cigarettes via its 2018 investment in Juul Labs, which lost it billions of dollars.

It made a new bet via the acquisition of pod-based vape NJOY ACE in June, but NJOY lags far behind Juul in terms of market share. Altria said the reported shipment volume for NJOY ACE in the third quarter was about 7.5 million pods.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Analysts at Jefferies said the scant progress update on NJOY, combined with the slowdown in traction of its nicotine pouch product on!, meant the market may not view this as a good quarter for Altria.

A 36.7% increase in on! shipment volumes helped offset a decline in traditional moist-cut oral tobacco, but fell short of the 47.8% growth seen in the second quarter.

Overall, Altria's third quarter revenues net of excise taxes of $5.28 billion were also slightly behind analyst expectations, according to LSEG data.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.